Metro Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	48.75	48.65	44.69	40.27	42.26	28.33
Revenue Growth (YoY)	1.00%	8.87%	10.96%	-4.70%	49.14%	24.77%
Cost of Revenue	31.25	28.92	26.61	24.27	22.16	15.15
Gross Profit	17.5	19.73	18.08	16.01	20.09	13.18
Other Operating Expenses	11.97	12.32	9.21	8.71	8.11	7.46
Operating Expenses	11.97	12.32	9.21	8.71	8.11	7.46
Operating Income	5.53	7.4	8.87	7.3	11.98	5.72
Interest Expense	-0.65	-0.69	-0.73	-0.4	-0.37	-0.39
Interest & Investment Income	0.46	0.46	0.21	0.17	0.11	0.07
EBT Excluding Unusual Items	5.35	7.17	8.35	7.07	11.72	5.41
Gain (Loss) on Sale of Investments	-	-	-	0.08	0.79	1.82
Gain (Loss) on Sale of Assets	-	-	0.03	0.22	0.02	-
Other Unusual Items	-	-	0.16	0	0.07	0.05
Pretax Income	5.35	7.17	8.54	7.38	12.6	7.27
Income Tax Expense	2.31	2.61	2.29	2.36	3.17	1.79
Net Income	3.03	4.56	6.25	5.02	9.44	5.48
Net Income to Common	3.03	4.56	6.25	5.02	9.44	5.48
Net Income Growth	-53.54%	-27.02%	24.56%	-46.85%	72.32%	142.76%
Shares Outstanding (Basic)	1,096	979	822	822	822	808
Shares Outstanding (Diluted)	1,096	979	822	827	822	808
Shares Change (YoY)	33.33%	19.05%	-0.55%	0.55%	1.82%	0.62%
EPS (Basic)	0.00	0.00	0.01	0.01	0.01	0.01
EPS (Diluted)	0.00	0.00	0.01	0.01	0.01	0.01
EPS Growth	-65.25%	-38.70%	24.56%	-46.86%	69.25%	141.32%
Free Cash Flow	7.28	5.58	7.38	4.67	7.21	2.73
Free Cash Flow Per Share	0.01	0.01	0.01	0.01	0.01	0.00
Dividend Per Share	0.006	0.005	0.005	0.005	0.002	0.002
Dividend Growth	20.37%	1.89%	6.00%	212.50%	6.67%	7.14%
Gross Margin	35.91%	40.55%	40.46%	39.74%	47.55%	46.53%
Operating Margin	11.35%	15.22%	19.85%	18.12%	28.36%	20.18%
Profit Margin	6.22%	9.37%	13.98%	12.46%	22.33%	19.33%
Free Cash Flow Margin	14.93%	11.46%	16.52%	11.60%	17.05%	9.62%
EBITDA	8.95	10.62	11.66	9.97	13.99	7.22
EBITDA Margin	18.37%	21.84%	26.10%	24.76%	33.10%	25.47%
D&A For EBITDA	3.42	3.22	2.79	2.68	2.01	1.5
EBIT	5.53	7.4	8.87	7.3	11.98	5.72
EBIT Margin	11.35%	15.22%	19.85%	18.12%	28.36%	20.18%
Effective Tax Rate	43.25%	36.43%	26.86%	32.01%	25.12%	24.68%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.